News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 272479

Wednesday, 09/14/2016 5:26:32 AM

Wednesday, September 14, 2016 5:26:32 AM

Post# of 347009
Excellent post CP and all should read. I also don't see how one could try to say Peregrine has turned into a manufacturing company. I know I must jump ahead at times but along with IO combos I hope Researchers see the connection with flipped PS and just like how targeting this flipped PS can allow organ transplants last just 24-48 hours longer makes a big difference... finding the PS Targeting ways to make crops/food supply last longer will also pay big dividends. I still say Bayer Crop Science would be the perfect start for an announcement

Now back to my wheaties and almond milk for breakfast

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y